Testing a plant-based supplement to improve blood-thinning therapy after heart stent placement

This trial is testing whether berberine, a natural compound derived from plants, can help improve the effectiveness of blood-thinning medications in people who have recently had a stent placed in their heart arteries. After a stent placement, patients take two blood-thinning drugs (aspirin and clopidogrel) to prevent dangerous blood clots. The study will see if adding this medication to standard treatment makes the blood-thinning therapy work better and safer.

Some people don't respond well enough to clopidogrel, one of the standard blood-thinning medications, which can increase the risk of blood clots after a stent. Doctors can't simply increase doses of current medications because that raises bleeding risk. This trial explores whether this treatment could be a safer way to improve how well blood-thinning therapy works.